TELO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Telomir Pharmaceuticals Inc (TELO) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, bearish technical indicators, no significant trading trends, and lacks positive catalysts. Additionally, there is no strong signal from Intellectia Proprietary Trading Signals to suggest a short-term trading opportunity.
The stock is showing bearish technical indicators. The MACD is negatively expanding below 0, the RSI is neutral at 43.589, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 1.337) in pre-market, but there is no clear upward momentum.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance in Q4 2025 with a 28.88% YoY drop in net income and a 40% YoY drop in EPS. No recent congress trading data or influential figure activity.
In Q4 2025, revenue remained stagnant at 0, net income dropped to -2,061,193 (-28.88% YoY), and EPS fell to -0.06 (-40% YoY). Gross margin was also 0, showing no improvement.
No analyst rating or price target data available.
